-
Mashup Score: 0Early PSA response among Black and non-Black patients with advanced prostate cancer treated with apalutamide - 2 year(s) ago
Future Oncology recently published an article exploring prostate health following the administration of the medication apalutamide in a real-world urology practice setting.
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Early PSA response among Black and non-Black patients with advanced prostate cancer treated with apalutamide - 2 year(s) ago
Future Oncology recently published an article exploring prostate health following the administration of the medication apalutamide in a real-world urology practice setting.
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Future Oncology, (@FutureOncol_FSG ) our partner journal, has recently published a Short Communication article exploring prostate health following the administration of the medication apalutamide. Find out more here >>> https://t.co/c4YHqyPbZT #ProstateCancer #PCAM
-
-
Mashup Score: 0Early PSA response among Black and non-Black patients with advanced prostate cancer treated with apalutamide - 2 year(s) ago
Future Oncology recently published an article exploring prostate health following the administration of the medication apalutamide in a real-world urology practice setting.
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Discover the effect of apalutamide on PSA response in Black and non-Black patients in this article from @FutureOncol_FSG >>> https://t.co/nFJpKxFPSR #ProstateCancer #PCAM
-
-
Mashup Score: 2Treatment Choices for Men With Early-Stage Prostate Cancer - 2 year(s) ago
Covers the treatment options for early-stage prostate cancer, such as active surveillance, surgery, and radiation therapy, and helps men decide which treatment is the best for them.
Source: National Cancer InstituteCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
To help men with early-stage prostate cancer understand the choices they have for treatment, NCI created a booklet that discusses all the options. Check it out. https://t.co/rgvh9VgKkI #pcam https://t.co/TLxOTGCAFO
-
-
Mashup Score: 0An Imaging Agent (Perflutren Lipid Microspheres) With Ultrasound for Imaging of Prostate Cancer - Full Text View - ClinicalTrials.gov - 2 year(s) ago
An Imaging Agent (Perflutren Lipid Microspheres) With Ultrasound for Imaging of Prostate Cancer – Full Text View.
Source: www.clinicaltrials.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
SKCC & @JeffersonRads' Dr. Flemming Forsberg and team are exploring whether tiny gas-filled #microbubbles may enhance ultrasound images of the prostate & help doctors identify #ProstateCancer on ultrasound: https://t.co/HULQ4OXelE #TrialTuesday #ProstateCancerAwarenessMonth #PCAM https://t.co/hp3ZN5K8R9
-
-
Mashup Score: 0TALAPRO-2: talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer - 2 year(s) ago
A recent clinical trial protocol describes the design and rationale of the multinational, Phase III, two-part TALAPRO-2 study.
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
In our latest video Neeraj Agarwal (University of Utah) discusses a recent publication exploring the TALAPRO-2 trial. View the full video here >>> https://t.co/Pq6qPYe9ar @VJofBiomedicine #PCAM #ProstateCancerAwarenessMonth #pcsm
-
-
Mashup Score: 0Publication In Focus: TALAPRO-2 - 2 year(s) ago
This Publication In Focus showcases content that provide further details of the TALAPRO-2 trial in various multimedia content types.
Source: Oncology CentralCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Check out our latest 'Publication In Focus' to find out further details of the TALAPRO-2 study through various multimedia content types. https://t.co/HkaauRfcvg #PCAM #ProstateCancerAwarenessMonth #pcsm
-
-
Mashup Score: 2
Pancreatic cancer is highly aggressive and difficult to treat, but now our scientists are taking a more personalised approach. For Pancreatic Cancer Awareness Month, Gege Li looks at how our researchers are using artificial intelligence to improve treatment.
Source: www.icr.ac.ukCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
This #PancreaticCancerAwarenessMonth, find out how the ICR's @LabSadanandam is using #AI to take a personalised approach to treating this aggressive cancer: https://t.co/TzkoZ2pCGw #PancreaticCancer #PurpleLightsUK #PCAM #ArtificialIntelligence
-
-
Mashup Score: 0Commentary: Tackling Prostate Cancer Screening Controversies—5 Things Men Should Know - Merck Manuals Consumer Version - 3 year(s) ago
As we get older, making smart choices about our health means getting proactive about identifying potential conditions or complications. Most of the time, the earlier you identify a change in your health, the more effectively you’ll be able to tackle those challenges and stay healthy. But that’s not always the case. In some instances,…
Source: Merck Manuals Consumer VersionCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
SKCC & @JEFFUrology's Dr. @LeonardGomella discusses five things men should know about #ProstateCancer screening: https://t.co/iehaGDQmDX @MerckManualHome #ProstateCancerAwarenessMonth #PCSM #PCAM #CancerScreening
-
-
Mashup Score: 3
Multiparametric MRI in Evaluating Cancer Stage and Helping Treatment Planning in Patients With Prostate Cancer – Full Text View.
Source: www.clinicaltrials.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#TrialTuesday: A #ClinicalTrial led by SKCC & @JEFFUrology's Dr. Edouard Trabulsi that will help determine if multiparametric #MRI is useful for patients with #ProstateCancer: https://t.co/J4r4DZyqNZ @eaonc #ProstateCancerAwarenessMonth #PCAM #JeffersonResearch https://t.co/vTyCAj818G
-
Find out about real-world PSA responses between Black and non-Black patients initiating apalutamide for advanced prostate cancer @FutureOncol_FSG https://t.co/7VFxmIKqpZ #ProstateCancer #PCAM